scholarly journals CORR Insights®: What Are the Long-term Results of MUTARS® Modular Endoprostheses for Reconstruction of Tumor Resection of the Distal Femur and Proximal Tibia?

2016 ◽  
Vol 475 (3) ◽  
pp. 719-721 ◽  
Author(s):  
Hannes A. Rüdiger
Keyword(s):  
Distal Femur ◽  
Proximal Tibia ◽  
Tumor Resection ◽  
Long Term Results

scholarly journals What Are the Long-term Results of MUTARS® Modular Endoprostheses for Reconstruction of Tumor Resection of the Distal Femur and Proximal Tibia?

2015 ◽  
Vol 475 (3) ◽  
pp. 708-718 ◽  
Author(s):  
Michaël P. A. Bus ◽  
Michiel A. J. van de Sande ◽  
Marta Fiocco ◽  
Gerard R. Schaap ◽  
Jos A. M. Bramer ◽  
...  
Keyword(s):  
Distal Femur ◽  
Proximal Tibia ◽  
Tumor Resection ◽  
Long Term Results

scholarly journals Erratum to: What Are the Long-term Results of MUTARS® Modular Endoprostheses for Reconstruction of Tumor Resection of the Distal Femur and Proximal Tibia?

2016 ◽  
Vol 475 (3) ◽  
pp. 922-922 ◽  
Author(s):  
Michaël P. A. Bus ◽  
Michiel A. J. van de Sande ◽  
Marta Fiocco ◽  
Gerard R. Schaap ◽  
Jos A. M. Bramer ◽  
...  
Keyword(s):  
Distal Femur ◽  
Proximal Tibia ◽  
Tumor Resection ◽  
Long Term Results

scholarly journals Surgical treatment of pulmonary artery sarcoma: a report of 17 cases

2021 ◽  
Vol 11 (1) ◽  
pp. 204589402098639
Author(s):  
Wu Song ◽  
Long Deng ◽  
Jiade Zhu ◽  
Shanshan Zheng ◽  
Haiping Wang ◽  
...  
Keyword(s):  
Pulmonary Artery ◽  
Survival Rates ◽  
Tumor Resection ◽  
Long Term Results ◽  
Pulmonary Endarterectomy ◽  
Pulmonary Artery Sarcoma ◽  
The Mean ◽  
Operative Findings

Pulmonary artery sarcoma (PAS) is a rare and devastating disease. The diagnosis is often delayed, and optimal treatment remains unclear. The aim of this study is to report our experience in the surgical management of this disease. Between 2000 and 2018, 17 patients underwent operations for PAS at our center. The medical records were retrospectively reviewed to evaluate the clinical characteristics, operative findings, the postoperative outcomes, and the long-term results. The mean age at operation was 46.0 ± 12.4 years (range, 26–79 years), and eight (47.1%) patients were male. Six patients underwent tumor resection alone, whereas the other 11 patients received pulmonary endarterectomy (PEA). There were two perioperative deaths. Follow-up was completed for all patients with a mean duration of 23.5 ± 17.6 months (1–52 months). For all 17 patients, the median postoperative survival was 36 months, and estimated cumulative survival rates at 1, 2, 3, and 4 years were 60.0%, 51.4%, 42.9%, and 21.4%, respectively. The mean survival was 37.0 months after PEA and 14.6 months after tumor resection only ( p = 0.046). Patients who had no pulmonary hypertension (PH) postoperatively were associated with improved median survival (48 vs. 5 months, p = 0.023). In conclusion, PAS is often mistaken for chronic pulmonary thromboembolism. The prognosis of this very infrequent disease remains poor. Early detection is essential for prompt and best surgical approach, superior to tumor resection alone, and PEA surgery with PH relieved can provide better chance of survival.

Long-term results of mandibular reconstruction with autogenous bone grafts and oral implants after tumor resection

2008 ◽  
Vol 19 (10) ◽  
pp. 1074-1080 ◽  
Author(s):  
Matteo Chiapasco ◽  
Giacomo Colletti ◽  
Eugenio Romeo ◽  
Marco Zaniboni ◽  
Roberto Brusati
Keyword(s):  
Tumor Resection ◽  
Bone Grafts ◽  
Mandibular Reconstruction ◽  
Long Term Results ◽  
Autogenous Bone ◽  
Oral Implants ◽  
Autogenous Bone Grafts

Favorable Long-Term Results of Prosthetic Arthroplasty of the Knee for Distal Femur Neoplasms

2005 ◽  
Vol &NA; (438) ◽  
pp. 65-70 ◽  
Author(s):  
Spencer J Frink ◽  
Janie Rutledge ◽  
Valerae O Lewis ◽  
Patrick P Lin ◽  
Alan W Yasko
Keyword(s):  
Distal Femur ◽  
Long Term Results

scholarly journals Influence of neodymium laser radiation on the frequency of recurrence and continued growth of extramedullary tumors

2021 ◽  
Vol 18 (3) ◽  
pp. 77-85
Author(s):  
I. A. Eliseenko ◽  
S. G. Struts ◽  
V. V. Stupak
Keyword(s):  
Laser Radiation ◽  
Tumor Resection ◽  
Relative Number ◽  
Neodymium Laser ◽  
Long Term Results ◽  
Primary Tumors ◽  
Classical Technique ◽  
Long Term Follow Up ◽  
Microsurgical Techniques

Objective. To assess the effect of neodymium laser radiation on the recurrence rate and continued growth of primary extramedullary tumors on the basis of clinical data obtained in the long-term follow-up period in operated patients with extramedullary tumors.Material and Methods. The long-term results of surgical treatment of two groups of patients (n = 412) with primary extramedullary tumors operated on from 1998 to 2014 were studied and systematized. Patients of comparison group (n = 277; 67.2 %) underwent removal of tumors using standard microsurgical techniques, and the neoplasms in patients of the study group (n = 135; 32.8 %) were removed with additionally used neodymium (Nd:YAG) laser.Results. The use of the developed laser technologies for the resection of extramedullary intracanal primary tumors made it possible to reliably reduce the relative number of recurrence and continued growth from 11.1 % to 1.2% compared with patients treated with standard surgery methods. The proportion of recurrences was 3.5 %, all of them were detected only in the group with the classical technique of tumor resection (p <0.01).Conclusion. The use of a neodymium laser as an additional technology to the classical microsurgical resection of extramedullary tumors is effective for the prevention of their recurrence and continued growth.

The long-term results of endoprosthetic replacement of the proximal tibia for bone tumours

2007 ◽  
Vol 89-B (12) ◽  
pp. 1632-1637 ◽  
Author(s):  
G. J. C. Myers ◽  
A. T. Abudu ◽  
S. R. Carter ◽  
R. M. Tillman ◽  
R. J. Grimer
Keyword(s):  
Proximal Tibia ◽  
Long Term Results ◽  
Bone Tumours ◽  
Endoprosthetic Replacement

Neurosurgical treatment of pediatric pleomorphic xanthoastrocytomas: long-term follow-up of a single-institution, consecutive series of 12 patients

2019 ◽  
Vol 23 (4) ◽  
pp. 512-516
Author(s):  
Tryggve Lundar ◽  
Bernt Johan Due-Tønnessen ◽  
Radek Frič ◽  
Bård Krossnes ◽  
Petter Brandal ◽  
...  
Keyword(s):  
Adjuvant Therapy ◽  
Primary Tumor ◽  
Barthel Index ◽  
Tumor Resection ◽  
Long Term Results ◽  
Primary Tumor Resection ◽  
Low Grade ◽  
Initial Operation

OBJECTIVEThe authors conducted a study to delineate the long-term results of the surgical treatment of pediatric pleomorphic xanthoastrocytomas (PXAs).METHODSAll consecutive children and adolescents (0–20 years) who underwent primary tumor resection for a PXA during the years 1972–2015 were included in this retrospective study on surgical morbidity, mortality rate, academic achievement, and/or work participation. Gross motor function and activities of daily living were scored according to the Barthel Index.RESULTSOf the 12 patients, 8 patients were in the 1st decade of life and 4 in the 2nd. The male/female ratio was 6:6. No patient was lost to follow-up. One patient presented with severe progressive tumor disease and died within 3 months after repeated resection. Another child died 3 days following a second surgical procedure involving gross-total resection (GTR) 8 years after the initial operation. The other 10 patients were alive at the latest follow-up when they reached the median age of 34 years (range 11–60 years). The median follow-up duration was 22 years (range 2–41 years). Barthel Index score was 100 in all 10 survivors. A total 18 tumor resections were performed. Five patients underwent a second tumor resection after MRI/CT confirmed recurrent tumor disease, from 6 months up to 17 years after the initial operation. Only one of our patients received adjuvant therapy: a 19-year-old male who underwent resection (GTR) for a right-sided temporal tumor in 1976. This particular tumor was originally classified as astrocytoma WHO grade IV, and postoperative radiotherapy (54 Gy) was given. The histology was reclassified to that of a PXA. Seven of 8 children whose primary tumor resection was performed more than 20 years ago are alive as of this writing—i.e., 88% observed 20-year survival. These are long-term survivors with good clinical function and all are in full- or part-time work.CONCLUSIONSPediatric patients with PXA can be treated with resection alone with rewarding results. Recurrences are not uncommon, but repeated surgery is well tolerated and should be considered in low-grade cases before adjuvant therapy is implemented. Follow-up including repeated MRI is important during the first postoperative years, since individual patients may have a more aggressive tumor course.

Sign in / Sign up

Export Citation Format

Share Document